1-(4-溴-3-羟基苯基)乙酮 | 73898-22-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 1-(4-溴-3-羟基苯基)乙酮
• 中文别名: 3-羟基-4-溴苯乙酮
• 英文名称: 1-(4-bromo-3-hydroxyphenyl)ethanone
• 英文别名: 4'-bromo-3'-hydroxyacetophenone
• CAS: 73898-22-3
• 化学式: C₈H₇BrO₂
• mdl: MFCD17169042
• 分子量: 215.046
• InChiKey: DLSQLGHKHPBHQB-UHFFFAOYSA-N

物化性质

• 熔点：
  122–123°C
• 沸点：
  310.5±32.0 °C(Predicted)
• 密度：
  1.586±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2914700090

反应信息

• 作为反应物：
  描述：

  1-(4-溴-3-羟基苯基)乙酮 在 盐酸 、 sodium tetrahydroborate 、 1,4-dioxane dibromide 、 乌洛托品 作用下， 以 1,4-二氧六环 、 乙醚 、 水 为溶剂， 反应 12.5h， 生成 5-(2-Amino-1-hydroxy-ethyl)-2-bromo-phenol
  参考文献：
  名称：

  Synthesis and structure-activity relationships among .alpha.-adrenergic receptor agonists of the phenylethanolamine type

  摘要：

  Nineteen arylethanolamine derivatives related to norepinephrine were prepared and tested for alpha-adrenergic stimulant activity. In one series the analogues possess a p-hydroxy function, while the meta position is substituted by methyl, ethyl, isopropyl, chlohexyl, fluoro, chloro, iodo, carboxy, carbomethoxy, and methylsulfamido groups. The other series is meta hydroxylated with the para position substituted by the same groups. The influence of these groups upon the alpha-adrenergic activity is discussed, and the compounds are compared to octopamine, normetanephrine, norepinephrine, and norphenylephrine. It has been found that the introduction of an isopropyl, cyclohexyl, and fluoro group in the meta position of octopamine improves its affinity by three, five, and six times, respectively, whereas when these groups are introduced in the para position of norphenylephrine their effects are always detrimental. The most active compound, alpha-(aminomethyl)(4-fluoro-3-hydroxyphenyl)methanol (44), has about one-hundredth the affinity and the same intrinsic activity as norepinephrine.

  DOI：

  10.1021/jm00181a008
• 作为产物：
  描述：

  1-(3-氨基-4-溴苯基)乙酮 5-乙酰基-2-溴苯胺 在 tetrafluoroboric acid 、 硫酸 、 sodium nitrite 作用下， 以 水 为溶剂， 反应 1.5h， 生成 1-(4-溴-3-羟基苯基)乙酮
  参考文献：
  名称：

  [EN] SUBSTITUTED BICYCLIC HCV INHIBITORS
  [FR] INHIBITEURS BICYCLIQUES SUBSTITUÉS DU VIRUS DE L'HÉPATITE C

  摘要：

  公开号：

  WO2012040389A3

文献信息

• [EN] BROMODOMAIN INHIBITORS<br/>[FR] INHIBITEURS DE BROMODOMAINE
  申请人：ABBVIE INC

  公开号：WO2014206150A1

  公开（公告）日：2014-12-31

  The present invention provides for compounds of formula (I). wherein Rx, Ry, Rx1, L1, G1, A1, A2, A3, and A4 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprised of one or more compounds of formula (I).

  本发明提供了式（I）的化合物。其中Rx、Ry、Rx1、L1、G1、A1、A2、A3和A4具有规范中定义的任何值，并且其药学上可接受的盐，可用作治疗疾病和病症的药剂，包括炎症性疾病、癌症和艾滋病。还提供了由一种或多种式（I）的化合物组成的药物组合物。
• Iron-catalyzed arene C−H hydroxylation
  作者：Lu Cheng、Huihui Wang、Hengrui Cai、Jie Zhang、Xu Gong、Wei Han

  DOI：10.1126/science.abj0731

  日期：2021.10

  selective catalytic hydroxylation of arenes remains an ongoing research challenge because of the relative inertness of aryl carbon-hydrogen bonds, the higher reactivity of the phenolic products leading to over-oxidized by-products, and the frequently insufficient regioselectivity. We report that iron coordinated by a bioinspired l-cystine–derived ligand can catalyze undirected arene carbon-hydrogen hydroxylation

  由于芳基碳氢键的相对惰性、酚类产物的较高反应性导致过度氧化的副产物以及经常不足的区域选择性，芳烃的可持续、非定向和选择性催化羟基化仍然是一项持续的研究挑战。我们报告说，铁由受生物启发的l-胱氨酸衍生的配体可以催化非定向芳烃碳氢羟基化，过氧化氢作为末端氧化剂。该反应以其广泛的底物范围、出色的选择性和良好的产率而著称，并且表现出与氧化敏感官能团的相容性，如醇、多酚、醛，甚至硼酸。该方法非常适合通过多重碳氢羟基化合成多酚，以及天然产物和药物分子的后期功能化。
• [EN] SUBSTITUTED BICYCLIC HCV INHIBITORS<br/>[FR] INHIBITEURS BICYCLIQUES DU VHC SUBSTITUÉS
  申请人：PRESIDIO PHARMACEUTICALS INC

  公开号：WO2010111673A1

  公开（公告）日：2010-09-30

  Provided herein are compounds, pharmaceutical compositions and combination therapies for treatment of hepatitis C.

  本文提供了用于治疗丙型肝炎的化合物、药物组合和联合疗法。
• [EN] METALLOENZYME INHIBITOR COMPOUNDS<br/>[FR] COMPOSÉS INHIBITEURS DE MÉTALLOENZYME
  申请人：VIAMET PHARMACEUTICALS INC

  公开号：WO2014117090A1

  公开（公告）日：2014-07-31

  The instant invention describes compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.

  这项即时发明描述了具有金属酶调节活性的化合物，以及治疗由这些金属酶介导的疾病、疾病或症状的方法。
• BIARYL AMIDE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
  申请人：Katayama Seiji

  公开号：US20130116227A1

  公开（公告）日：2013-05-09

  Disclosed is a novel biaryl amide derivative represented by formula (1) and having an affinity for the aldosterone receptor; also disclosed is a pharmaceutically acceptable salt thereof. (In the formula, A is any of the groups represented by formula (a); L is —CONH—, etc.; R 1 is a substitutable aminosulfonyl group, etc.; R 2 is a hydrogen atom, etc.; R 3 is a hydrogen atom, etc.; R 4 is a hydrogen atom, a halogen atom, hydroxy group, a substitutable amino group, a substitutable C 1-6 alkoxy group, a substitutable 4- to 7-membered cyclic amino group, etc.; R 5a , R 5b and R 5c are each independently hydrogen atoms, etc.; R 6 is a halogen atom, a cyano group, etc.; R 7 and R 8 are each independently a hydrogen atom, etc.; and m is an integer such as 0.)

  揭示了一种表示为公式（1）的新型联苯酰胺衍生物，具有与醛固酮受体的亲和力；还揭示了其药用可接受的盐。（在该公式中，A是由公式（a）表示的任何基团之一；L是—CONH—等；R1是可替代的氨基磺酰基等；R2是氢原子等；R3是氢原子等；R4是氢原子、卤原子、羟基、可替代的氨基基团、可替代的C1-6烷氧基、可替代的4-到7-成员环氨基基团等；R5a、R5b和R5c各自独立地是氢原子等；R6是卤原子、氰基等；R7和R8各自独立地是氢原子等；m是整数，例如0。）